AAOS Physicians Discuss Treatment for Dupuytren Contracture

In the latest addition of AAOS Now, D. Kay Kirkpatrick, MD, a hand surgeon and member of the AAOS practice management committee, led a discussion about the recently FDA-approved enzyme injection treatment for Dupuytren contracture.

Advertisement

The enzyme injection includes collagenase clostridium histolyticum, an enzyme meant to soften and weaken the diseased tissue cords that cause fingers to contract. Further treatment options, such as the minimally invasive needle aponeurotonomy, can also be an alternative to traditional surgery.

The discussion focuses on many topics, including the clinical value of alternative treatment and the risks involved in the procedure.

Read the AAOS Now article on treatment for Dupuytren contracture.

Read other coverage on AAOS:

– AAOS Supports Metal-on-Metal Hip Replacements But Urges Physicians to Educate Patients First

– AAOS: Surgical Error Data for Orthopedics May Be Misleading

– AAOS Explains Vertebroplasty Guidelines

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.